Jun 4, 2026 07:01AM
Jun 4, 2026 07:00AM
May 15, 2026 06:36AM
May 15, 2026 05:00AM
May 14, 2026 07:00AM
Apr 20, 2026 09:00AM
Apr 20, 2026 06:43AM Psychedelic drug developers rally after Trump orders FDA to expedite reviews
Apr 20, 2026 06:08AM
Mar 10, 2026 06:43AM
Mar 6, 2026 07:05AM
Mar 6, 2026 04:44AM
Mar 5, 2026 07:01AM
Mar 5, 2026 07:00AM
Jan 6, 2026 06:29AM GH Research PLC (GHRS) PT Raised to $39 at Canaccord Genuity
Jan 6, 2026 05:05AM
Jan 5, 2026 11:52AM
Jan 5, 2026 09:59AM
Jan 5, 2026 07:34AM
Jan 5, 2026 07:01AM
Jan 5, 2026 07:00AM
Jan 2, 2026 04:19PM GH Research soars on planned FDA update on depression drug candidate
Jan 2, 2026 04:01PM
Jan 2, 2026 04:01PM
Nov 6, 2025 07:00AM
Sep 10, 2025 09:16AM
Aug 7, 2025 10:21AM
Aug 7, 2025 07:00AM
Jul 25, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on GH Research PLC (GHRS)
Jul 24, 2025 04:38AM
Jul 23, 2025 08:02AM
Jul 23, 2025 08:00AM
Jul 10, 2025 06:45AM
Jun 20, 2025 01:01PM
Jun 20, 2025 01:00PM
May 15, 2025 07:00AM GH Research Announces Acceptance of Pharmaceutical Pipeline Presentation and Late-Breaking Posters at the American Society of Clinical Psychopharmacology 2025 Annual Meeting
May 8, 2025 07:00AM
Mar 5, 2025 06:49AM
Feb 27, 2025 07:00AM
Feb 26, 2025 04:16PM
Feb 13, 2025 06:32AM
Jan 27, 2025 07:22AM
Jan 10, 2025 07:07AM GH Research (GHRS) Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-Rodents
Jan 10, 2025 07:00AM
Nov 20, 2024 07:25AM
Nov 14, 2024 07:00AM
Sep 6, 2024 06:54AM
Sep 3, 2024 07:05AM
Sep 3, 2024 07:02AM
Sep 3, 2024 07:00AM GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer
May 3, 2024 07:00AM

323,577 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All